UCB USA
在场
UCB USA 的所有者是 UCB.
是其中之一......
UCB 是一家在股票代码 UCB (BE) 下上市的公司。
UCB 在 10 个国家有直接业务。UCB 拥有 10家子公司，其中包括 UCB Australia、UCB Canada 和 UCB France。
他们在：
高管
查看带有其 13 名主要高管的组织结构图
UCB USA 搜索最多的简介
- Taco Van Tiel, Managing Director
- Kimberly Moran, Head, Rare Disease
- Brandon Drew, Global Head of Developed Brands
创建提醒
跟踪 UCB USA 的高管变动
药店
UCB 拥有 1,831 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Stemtech and Seacret Direct have announced they will merge (公布2024十二月5号)..
- Recursion Pharma and Exscientia have merged (公布2024十一月27号)..
- Stemtech and Seacret Direct have announced they will merge (公布2024十一月22号)..
药店 行业的其他推荐联系人
消息
UCB USA 的最新新闻稿
- Charting the Future: UCB’s 2024 Achievements are Fueling our 2025 Ambitions | UCBBack ButtonSearch IconFilter Icon
- UCB Presents New Data on Impact and Burden of Epilepsy at 2024 American Epilepsy Society (AES) Annual Meeting | UCBBack ButtonSearch IconFilter Icon
- UCB U.S. News | UCBBack ButtonSearch IconFilter Icon
- UCB U.S. News | UCBBack ButtonSearch IconFilter Icon
- UCB presents latest scientific research in epilepsy at American Epilepsy Society (AES) Annual Meeting | UCBBack ButtonSearch IconFilter Icon
- UCB Receives U.S. FDA Approval for BIMZELX® (bimekizumab-bkzx) as the First IL-17A and IL-17F Inhibitor for Adults with Moderate-to-Severe Hidradenitis Suppurativa | UCBBack ButtonSearch IconFilter Icon
- Closing gaps in HS care through community engagement and scientific innovation | UCBBack ButtonSearch IconFilter Icon
- UCB U.S. News | UCBBack ButtonSearch IconFilter Icon
- A Bright Future: Prioritizing Early Diagnosis, Maintenance, and Remissions in Rheumatology | UCBBack ButtonSearch IconFilter Icon
- New BIMZELX® (bimekizumab-bkzx) Data at ACR Convergence 2024 Highlights UCB’s Efforts to Deliver Differentiated Care for Patients with Psoriatic Arthritis and Axial Spondyloarthritis | UCBBack ButtonSearch IconFilter Icon
- View more press releases Close
通过电子邮件
